/Lists

Healthtech Series B Investors & VC Firms

1027 firms in this list, with a median first check of $540K. 256 of them lead rounds. Generated from verified public data and updated continuously.

ACT Venture Capital
DublinSeed–Growth$1.1M – $16.2M
11 people
Bioqube Ventures
BrusselsPre-Seed–Series B$108K – $6.5M
17 people
Amplitude Venture Capital
MontrealPre-Seed–Series B
16 people
DNA Capital
São PauloSeed–Late Stage$100K – $5M
15 people
Impact America Fund
IrvineSeed–Series B$250K – $3M
10 people
Athera Venture Partners
BangaloreSeed–Series B$480K – $3M
9 people
Pappas Capital
Research Triangle ParkSeed–Late Stage$100K – $6M
15 people
Portugal Ventures
PortoPre-Seed–Series C$54K – $1.6M
12 people
DeepTechXL
EindhovenPre-Seed–Series C$108K – $2.2M
17 people
JK&B Capital
ChicagoSeed–Late Stage
9 people
Celtic House Asia Partners
TorontoPre-Seed–Late Stage
4 people
Cohen Circle
New YorkPre-Seed–Late Stage
13 people
Maor Investments
Tel AvivSeries B–Growth$6M – $10M
10 people
Adelie
ParisSeed–Growth$2.2M – $10.8M
8 people
BrightEdge
AtlantaPre-Seed–Late Stage
15 people
Boehringer Ingelheim Venture Fund
Ingelheim am RheinSeed–Growth$16.2M
16 people
Mount Judi Ventures
BengaluruPre-Seed–Series B
16 people
New Science Ventures
GreenwichSeed–Late Stage$2M – $8M
7 people
EFung Capital
ShenzhenSeries A–Growth
Life Sciences Greenhouse Investments
HarrisburgPre-Seed–Series B$250K – $500K
12 people
NovaCapital
Seed–Late Stage
9 people
Gilead Sciences
Foster CitySeries B–Late Stage
19 people
Seroba Life Sciences
DublinSeed–Growth$540K – $7.6M
13 people
Bios Partners
Fort WorthSeed–Growth
17 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.